Ensysce Biosciences Inc (ENSC)
US$ 1.8712.65%
Price Chart
Key Statistics
Market Cap
$ 2.63M
P/E Ratio
0.00
Revenue (TTM)
$ 5.21M
Volume
78.49K
52W High
$ 14.67
52W Low
$ 1.62
Dividend Yield
0.00%
Beta
1.07
Technicals
50-Day MA
3.885
200-Day MA
5.9306
52 Week High
14.67
52 Week Low
1.62
About ENSC
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
Employees
7
Headquarters
La Jolla, CA
CEO
Dr. D. Lynn Kirkpatrick Ph.D.
Latest News
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
5 hours ago • Google News
(ENSC) Technical Data - news.stocktradersdaily.com
15 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg